首页> Journal of clinical psychopharmacology> Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.

Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.

导出原文传递

翻译打印收藏纠错

第一作者： Saddichha S

作者： Saddichha S ^[1] ; Ameen S ; Akhtar S

作者单位： Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India. saddichha@gmail.com ^[1]

关键词 Weight Gain olanzapine Risperidone Haloperidol Body Mass Index 体重增长利哌立酮氟哌啶醇人体质量指数

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Journal of clinical psychopharmacology

2008年28卷1期

27-31页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Journal of clinical psychopharmacology

2008年28卷1期

27-31页

检索历史清除

Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.

Journal of clinical psychopharmacology

相似文献

同项目论文

Journal of clinical psychopharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.

Journal of clinical psychopharmacology

相似文献

同项目论文

Journal of clinical psychopharmacology

相关期刊

检索历史清除